SCHEMBL14214645

SCHEMBL14214645

CCOC(=O)c1ncsc1CF

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.41
ALDH1A1 P00352 4/20 0.40
NPC1 O15118 3/20 0.40
MAPT P10636 3/20 0.40
HSD17B10 Q99714 2/20 0.40
TP53 P04637 1/20 0.40
XBP1 P17861 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TLR9 Q9NR96 1/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 2/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
CYP1A2 P05177 2/20 0.40
ILK Q13418 1/20 0.39
RAB9A P51151 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3330523 0.85 ALDH1A1 (0.44) BRD4ALDH1A1NPC1MAPTHSD17B10
SCHEMBL2024194 0.84 BRD4 (0.41) BRD4ALDH1A1NPC1MAPTHSD17B10
SCHEMBL11708039 0.84 BRD4 (0.41) BRD4ALDH1A1NPC1MAPTHSD17B10
SCHEMBL27757230 0.81 BRD4 (0.40) BRD4ALDH1A1NPC1MAPTHSD17B10
SCHEMBL29598453 0.80 KDM4E (0.42) BRD4ALDH1A1NPC1MAPTHSD17B10
SCHEMBL29598150 0.80 HDAC3 (0.39) BRD4ALDH1A1NPC1MAPTHSD17B10
SCHEMBL29605580 0.80 CYP4F2 (0.42) BRD4ALDH1A1MAPTHSD17B10TSHR
SCHEMBL29572339 0.80 CYP4F2 (0.43) BRD4ALDH1A1HSD17B10TSHRKDM4E
SCHEMBL2022385 0.80 TSHR (0.44) BRD4ALDH1A1NPC1MAPTHSD17B10
SCHEMBL29597836 0.79 BRD4 (0.41) BRD4ALDH1A1NPC1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080124384-A1 Heteroaryl Substituted Piperazinyl-Pyridine Analogues NEUROGEN CORPORATION 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080124384-A1 Heteroaryl Substituted Piperazinyl-Pyridine Analogues PIGO, GPR52, GPR88 BRD4 716/4885ALDH1A1 1028/4885NPC1 2700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.